Published in Subcell Biochem on January 01, 1996
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
Medicinal plants in Mexico: healers' consensus and cultural importance. Soc Sci Med (1998) 5.51
Treatment of hypertension with ascorbic acid. Lancet (1999) 4.74
Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA (1997) 4.37
Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol (2000) 4.21
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med (1995) 3.60
Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N Engl J Med (1999) 3.21
Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet (1998) 3.06
Antioxidants and atherosclerotic heart disease. N Engl J Med (1997) 2.86
Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr (2001) 2.64
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology (2011) 2.52
Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials. N Engl J Med (1996) 2.48
Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci U S A (1991) 2.34
Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation (1996) 2.28
Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension (2000) 2.23
The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc (1999) 2.12
Migraine, headache, and the risk of stroke in women: a prospective study. Neurology (2005) 2.01
Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr (1999) 1.97
Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J (1999) 1.94
Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation (2001) 1.90
Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation (2001) 1.89
Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation (2001) 1.86
Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA damage. Free Radic Biol Med (2001) 1.71
US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol (2000) 1.71
Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Neurology (2008) 1.63
Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med (1997) 1.58
Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation (2000) 1.57
Body mass index and mortality in men: evaluating the shape of the association. Int J Obes (Lond) (2007) 1.57
Time urgency and risk of non-fatal myocardial infarction. Int J Epidemiol (2001) 1.55
Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med (2001) 1.55
An overview of trials of cholesterol lowering and risk of stroke. Arch Intern Med (1995) 1.54
Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study. Thorax (2008) 1.45
A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group. Ann Epidemiol (1995) 1.44
Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J (2001) 1.40
Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem (1997) 1.38
Stroke risk predicts verbal fluency decline in healthy older men: evidence from the normative aging study. J Gerontol B Psychol Sci Soc Sci (2001) 1.36
Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med (1999) 1.35
Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation (1999) 1.34
Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol (1996) 1.34
Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial. Ann Intern Med (1991) 1.33
Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med (2001) 1.30
Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. J Natl Cancer Inst (2001) 1.29
Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol (2000) 1.26
Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med (1990) 1.25
Lipid levels and the risk of ischemic stroke in women. Neurology (2007) 1.23
Antioxidants in tea. Crit Rev Food Sci Nutr (1997) 1.20
Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res (2000) 1.19
Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein. J Lipid Res (1993) 1.19
Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem (2000) 1.17
Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci U S A (1993) 1.16
Analgesic use and renal function in men. JAMA (2001) 1.13
Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem (1993) 1.12
Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J Lab Clin Med (1990) 1.12
Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest (1995) 1.11
Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol (1999) 1.10
Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis. FEBS Lett (2000) 1.09
Mechanism of alloxan-induced calcium release from rat liver mitochondria. J Biol Chem (1985) 1.09
Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation (1999) 1.08
Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in U.S. male physicians. Ann Intern Med (1997) 1.07
Ca2+ release from mitochondria induced by prooxidants. Free Radic Biol Med (1988) 1.06
Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest (1994) 1.06
Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci U S A (1994) 1.06
Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest (1994) 1.06
L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest (1998) 1.05
Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis. Eur J Clin Nutr (2011) 1.04
Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center. Hepatology (2001) 1.03
Antioxidants and cardiovascular disease: a review. J Am Coll Nutr (1993) 1.01
Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J Lipid Res (1993) 1.00
Royal colleges' advice on alcohol consumption. BMJ (1995) 0.99
Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J (2001) 0.99
The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radic Biol Med (2000) 0.98
'Spontaneous' genetic damage in man: evaluation of interindividual variability, relationship among markers of damage, and influence of nutritional status. Mutat Res (1997) 0.98
Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approach. J Thromb Haemost (2006) 0.97
Menadione- (2-methyl-1,4-naphthoquinone-) dependent enzymatic redox cycling and calcium release by mitochondria. Biochemistry (1986) 0.97
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia. Am J Med (2001) 0.96
Seven-year changes in alcohol consumption and subsequent risk of cardiovascular disease in men. Arch Intern Med (2000) 0.96
Measurement of antioxidants in human blood plasma. Methods Enzymol (1994) 0.96
Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic Biol Med (1998) 0.96
Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest (1995) 0.96
Diet and metabolic syndrome. Endocr Metab Immune Disord Drug Targets (2010) 0.95
Nut consumption and risk of type II diabetes in the Physicians' Health Study. Eur J Clin Nutr (2009) 0.95
Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation (1995) 0.94
Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscler Thromb Vasc Biol (1997) 0.94
Blood pressure measures and risk of total, ischemic, and hemorrhagic stroke in men. Neurology (2006) 0.93
Antioxidant status and indexes of oxidative stress during consecutive days of exercise. J Appl Physiol (1985) (1993) 0.92
Lipoic acid significantly restores, in rats, the age-related decline in vasomotion. Br J Pharmacol (2008) 0.92
Cigarette smoke oxidation of human plasma constituents. Ann N Y Acad Sci (1993) 0.92
Ozone causes lipid peroxidation but little antioxidant depletion in exercising and nonexercising hamsters. J Appl Physiol (1985) (2001) 0.91
Vibration detection and discrimination in the masked birch caterpillar (Drepana arcuata). J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2012) 0.91
Assay of lipid hydroperoxides using high-performance liquid chromatography with isoluminal chemiluminescence detection. Methods Enzymol (1990) 0.91
The effect of iron overload on rat plasma and liver oxidant status in vivo. Biochem J (1994) 0.91
History of diabetes mellitus and risk of prostate cancer in physicians. Am J Epidemiol (2004) 0.90
Early high dose antioxidant vitamins do not prevent bronchopulmonary dysplasia in premature baboons exposed to prolonged hyperoxia: a pilot study. Pediatr Res (1998) 0.90
Association between modifiable lifestyle factors and residual lifetime risk of diabetes. Nutr Metab Cardiovasc Dis (2011) 0.90